Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 175

1.

Dopamine genes and nicotine dependence in treatment-seeking and community smokers.

Bergen AW, Conti DV, Van Den Berg D, Lee W, Liu J, Li D, Guo N, Mi H, Thomas PD, Lessov-Schlaggar CN, Krasnow R, He Y, Nishita D, Jiang R, McClure JB, Tildesley E, Hops H, Tyndale RF, Benowitz NL, Lerman C, Swan GE.

Neuropsychopharmacology. 2009 Sep;34(10):2252-64. doi: 10.1038/npp.2009.52. Epub 2009 Jun 3.

2.
3.

Genetic variants and early cigarette smoking and nicotine dependence phenotypes in adolescents.

O'Loughlin J, Sylvestre MP, Labbe A, Low NC, Roy-Gagnon MH, Dugas EN, Karp I, Engert JC.

PLoS One. 2014 Dec 29;9(12):e115716. doi: 10.1371/journal.pone.0115716. eCollection 2014.

4.

Resequencing of nicotinic acetylcholine receptor genes and association of common and rare variants with the Fagerström test for nicotine dependence.

Wessel J, McDonald SM, Hinds DA, Stokowski RP, Javitz HS, Kennemer M, Krasnow R, Dirks W, Hardin J, Pitts SJ, Michel M, Jack L, Ballinger DG, McClure JB, Swan GE, Bergen AW.

Neuropsychopharmacology. 2010 Nov;35(12):2392-402. doi: 10.1038/npp.2010.120. Epub 2010 Aug 25.

5.

Dopamine and opioid gene variants are associated with increased smoking reward and reinforcement owing to negative mood.

Perkins KA, Lerman C, Grottenthaler A, Ciccocioppo MM, Milanak M, Conklin CA, Bergen AW, Benowitz NL.

Behav Pharmacol. 2008 Sep;19(5-6):641-9. doi: 10.1097/FBP.0b013e32830c367c.

6.

Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation.

David SP, Brown RA, Papandonatos GD, Kahler CW, Lloyd-Richardson EE, Munafò MR, Shields PG, Lerman C, Strong D, McCaffery J, Niaura R.

Nicotine Tob Res. 2007 Aug;9(8):821-33. Erratum in: Nicotine Tob Res. 2007 Nov;9(11):1243.

7.

Dopamine-related genes and spontaneous smoking cessation in ever-heavy smokers.

Breitling LP, Müller H, Illig T, Rujescu D, Winterer G, Dahmen N, Nitz B, Raum E, Rothenbacher D, Brenner H.

Pharmacogenomics. 2011 Aug;12(8):1099-106. doi: 10.2217/pgs.11.74. Epub 2011 Aug 1.

PMID:
21806388
8.

Influences of polymorphic variants of DRD2 and SLC6A3 genes, and their combinations on smoking in Polish population.

Sieminska A, Buczkowski K, Jassem E, Niedoszytko M, Tkacz E.

BMC Med Genet. 2009 Sep 17;10:92. doi: 10.1186/1471-2350-10-92.

9.

Ethnic- and gender-specific association of the nicotinic acetylcholine receptor alpha4 subunit gene (CHRNA4) with nicotine dependence.

Li MD, Beuten J, Ma JZ, Payne TJ, Lou XY, Garcia V, Duenes AS, Crews KM, Elston RC.

Hum Mol Genet. 2005 May 1;14(9):1211-9. Epub 2005 Mar 24.

10.

Convergent evidence that choline acetyltransferase gene variation is associated with prospective smoking cessation and nicotine dependence.

Ray R, Mitra N, Baldwin D, Guo M, Patterson F, Heitjan DF, Jepson C, Wileyto EP, Wei J, Payne T, Ma JZ, Li MD, Lerman C.

Neuropsychopharmacology. 2010 May;35(6):1374-82. doi: 10.1038/npp.2010.7. Epub 2010 Feb 10.

12.

A functional polymorphism, rs6280, in DRD3 is significantly associated with nicotine dependence in European-American smokers.

Huang W, Payne TJ, Ma JZ, Li MD.

Am J Med Genet B Neuropsychiatr Genet. 2008 Oct 5;147B(7):1109-15. doi: 10.1002/ajmg.b.30731.

PMID:
18348205
13.

[Association between nicotine dependence and the -521 promoter polymorfism of the dopamine D4 receptor in patients with major depression].

Kótyuk E, Kovács-Nagy R, Faludi G, Urbán R, Rónai Z, Sasvári-Székely M, Székely A.

Neuropsychopharmacol Hung. 2009 Jun;11(2):59-67. Hungarian.

14.

Association of CHRNA4 polymorphisms with smoking behavior in two populations.

Han S, Yang BZ, Kranzler HR, Oslin D, Anton R, Gelernter J.

Am J Med Genet B Neuropsychiatr Genet. 2011 Jun;156B(4):421-9. doi: 10.1002/ajmg.b.31177. Epub 2011 Mar 28.

15.

Influence of a dopamine pathway additive genetic efficacy score on smoking cessation: results from two randomized clinical trials of bupropion.

David SP, Strong DR, Leventhal AM, Lancaster MA, McGeary JE, Munafò MR, Bergen AW, Swan GE, Benowitz NL, Tyndale RF, Conti DV, Brown RA, Lerman C, Niaura R.

Addiction. 2013 Dec;108(12):2202-11. doi: 10.1111/add.12325. Epub 2013 Sep 18.

16.

Peer smoking and the nicotinic receptor genes: an examination of genetic and environmental risks for nicotine dependence.

Johnson EO, Chen LS, Breslau N, Hatsukami D, Robbins T, Saccone NL, Grucza RA, Bierut LJ.

Addiction. 2010 Nov;105(11):2014-22. doi: 10.1111/j.1360-0443.2010.03074.x. Epub 2010 Sep 15.

17.
18.

Dopaminergic gene polymorphisms and cognitive function in a north Indian schizophrenia cohort.

Kukshal P, Kodavali VC, Srivastava V, Wood J, McClain L, Bhatia T, Bhagwat AM, Deshpande SN, Nimgaonkar VL, Thelma BK.

J Psychiatr Res. 2013 Nov;47(11):1615-22. doi: 10.1016/j.jpsychires.2013.07.007. Epub 2013 Aug 8.

19.

Beta-arrestins 1 and 2 are associated with nicotine dependence in European American smokers.

Sun D, Ma JZ, Payne TJ, Li MD.

Mol Psychiatry. 2008 Apr;13(4):398-406. Epub 2007 Jun 19.

PMID:
17579607
20.

Haplotype analysis indicates an association between the DOPA decarboxylase (DDC) gene and nicotine dependence.

Ma JZ, Beuten J, Payne TJ, Dupont RT, Elston RC, Li MD.

Hum Mol Genet. 2005 Jun 15;14(12):1691-8. Epub 2005 May 6.

Items per page

Supplemental Content

Write to the Help Desk